Latest period
$114.02B
YoY change
+9.6%
5Y CAGR
+11.3%
Peak year (2025)
$114.07B
Latest annual
$114.07B
Total Assets history chart for AstraZeneca (AZN) from 1990 to 2025
Latest: $114.07B
Total Assets growth chart for AstraZeneca (AZN) from 1990 to 2025
Latest: +9.6%
Total Assets history table for AstraZeneca (AZN) from 1990 to 2025
| 2025 | $114.07B | +9.6% | +$10.04B | ||
| 2024 | $104.03B | +2.9% | +$2.92B | ||
| 2023 | $101.12B | +4.8% | +$4.64B | ||
| 2022 | $96.48B | -8.4% | −$8.88B | ||
| 2021 | $105.36B | +57.9% | +$38.63B | ||
| 2020 | $66.73B | +8.7% | +$5.35B | ||
| 2019 | $61.38B | +1.2% | +$726.00M | ||
| 2018 | $60.65B | -4.3% | −$2.70B | ||
| 2017 | $63.35B | +1.3% | +$828.00M | ||
| 2016 | $62.53B | +4.0% | +$2.40B | ||
| 2015 | $60.12B | +2.6% | +$1.53B | ||
| 2014 | $58.59B | +4.8% | +$2.70B | ||
| 2013 | $55.90B | +4.4% | +$2.37B | ||
| 2012 | $53.53B | +1.3% | +$704.00M | ||
| 2011 | $52.83B | -5.9% | −$3.30B | ||
| 2010 | $56.13B | +2.2% | +$1.21B | ||
| 2009 | $54.92B | +17.0% | +$7.97B | ||
| 2008 | $46.95B | -2.1% | −$1.01B | ||
| 2007 | $47.96B | +60.2% | +$18.02B | ||
| 2006 | $29.93B | +20.5% | +$5.09B | ||
| 2005 | $24.84B | -3.2% | −$812.00M | ||
| 2004 | $25.65B | +8.8% | +$2.08B | ||
| 2003 | $23.57B | +9.3% | +$2.00B | ||
| 2002 | $21.58B | -18.4% | −$4.87B | ||
| 2001 | $26.45B | +43.4% | +$8.00B | ||
| 2000 | $18.45B | -6.9% | −$1.36B | ||
| 1999 | $19.81B | +120.6% | +$10.83B | ||
| 1998 | $8.98B | +8.4% | +$697.91M | ||
| 1997 | $8.28B | -3.3% | −$280.44M | ||
| 1996 | $8.56B | +8.8% | +$692.75M | ||
| 1995 | $7.87B | +7.5% | +$551.48M | ||
| 1994 | $7.32B | -1.4% | −$105.82M | ||
| 1993 | $7.42B | +20.0% | +$1.24B | ||
| 1992 | $6.19B | -2.7% | −$173.94M | ||
| 1991 | $6.36B | +4.3% | +$260.81M | ||
| 1990 | $6.10B | — | — |
- 2025$114.07B+9.6%
- 2024$104.03B+2.9%
- 2023$101.12B+4.8%
- 2022$96.48B-8.4%
- 2021$105.36B+57.9%
- 2020$66.73B+8.7%
- 2019$61.38B+1.2%
- 2018$60.65B-4.3%
- 2017$63.35B+1.3%
- 2016$62.53B+4.0%
- 2015$60.12B+2.6%
- 2014$58.59B+4.8%
- 2013$55.90B+4.4%
- 2012$53.53B+1.3%
- 2011$52.83B-5.9%
- 2010$56.13B+2.2%
- 2009$54.92B+17.0%
- 2008$46.95B-2.1%
- 2007$47.96B+60.2%
- 2006$29.93B+20.5%
- 2005$24.84B-3.2%
- 2004$25.65B+8.8%
- 2003$23.57B+9.3%
- 2002$21.58B-18.4%
- 2001$26.45B+43.4%
- 2000$18.45B-6.9%
- 1999$19.81B+120.6%
- 1998$8.98B+8.4%
- 1997$8.28B-3.3%
- 1996$8.56B+8.8%
- 1995$7.87B+7.5%
- 1994$7.32B-1.4%
- 1993$7.42B+20.0%
- 1992$6.19B-2.7%
- 1991$6.36B+4.3%
- 1990$6.10B—
Total Assets values are taken from AstraZeneca's reported balance sheets (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported total assets is $114.02B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total assets for AstraZeneca (AZN) came in at $114.07B – grew 9.6% year-over-year.
AstraZeneca total assets has grown for 3 consecutive years, with a +11.3% compound annual growth rate over 2020–2025 (5 years).
The highest annual total assets of $114.07B was reported in 2025. The lowest in the available history was $6.10B in 1990.
AstraZeneca Total Assets by Year
AstraZeneca Total Assets 2025: $114.07B
AstraZeneca posted total assets of $114.07B in 2025, grew 9.6% from 2024. This figure represents the highest annual value in the available history.
AstraZeneca Total Assets 2024: $104.03B
In 2024, AstraZeneca reported total assets of $104.03B, edged up 2.9% from 2023.
AstraZeneca Total Assets 2023: $101.12B
AstraZeneca total assets in 2023 was $101.12B, edged up 4.8% from 2022.
AstraZeneca Total Assets 2022: $96.48B
2022's total assets for AstraZeneca came in at $96.48B, declined 8.4% below 2021.
AstraZeneca Total Assets 2021: $105.36B
AstraZeneca total assets in 2021 was $105.36B.
See more financial history for AstraZeneca (AZN).
Sector peers by Total Assets
Healthcare peers of AstraZeneca (AZN), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $112.48B | |
| $110.34B | |
| $90.59B | |
| $85.37B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $112.48B
- $110.34B
- $90.59B
- $85.37B
Frequently asked questions
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation